AD is the most common type of neurodegenerative diseases in the elderly, and it has been well established that the clinical symptoms of AD are characterized by β-amyloid (Aβ) plaques, phosphorylated Tau, and gliosis in the cerebral parenchyma, resulting in progressive cognition decline [158]. The gene discussed is MAPT; the disease is Alzheimer disease.